GENVAX TECHNOLOGY
Business Summary
Operates as a cancer vaccine venture developed at Monash and Griffith Universities. The Company has achieved preclinical outcomes, and seeks a venture partner to advance clinical studies of the vaccine and further expand the breadth of this platform technology. Genvax specializes in the development of high potency vaccines against cancers and other applications. Genvaxs core technology is based around a unique patented (applied) formulation that super inducesthe potency of the vaccine.
Country of Incorporation
Australia
Incorporation Date
-
Business Sector
Pharmaceuticals & Medical Research
Company Address
Monash University, Vc, Melbourne
Get access to the below data and more business development tools by signing up for the MENA Company Data product.
- Ownership details
- Corporate structure
- Business classification
- Officers & Directors contact details
- Full company contact details
Multiply your reach by contributing your content to LSEG
LSEG contributed content reaches tens of thousands of buy and sell side professionals around the world through an integrated suite of market intelligence and transaction platforms.NEWS ON THIS COMPANY
TOP PICKS
MOST READ
MOST WATCHED
MOST POPULAR
1.
2.
3.
4.
5.
